Triptolide inhibits the growth of osteosarcoma by regulating microRNA-181a via targeting PTEN gene in vivo and vitro
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triptolide inhibits the growth of osteosarcoma by regulating microRNA-181a via targeting PTEN gene in vivo and vitro
Authors
Keywords
-
Journal
TUMOR BIOLOGY
Volume 39, Issue 4, Pages 101042831769755
Publisher
SAGE Publications
Online
2017-04-06
DOI
10.1177/1010428317697556
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triptolide reduces the viability of osteosarcoma cells by reducing MKP-1 and Hsp70 expression
- (2016) LEI ZHAO et al. Experimental and Therapeutic Medicine
- Triptolide suppresses proliferation, hypoxia-inducible factor-1α and c-Myc expression in pancreatic cancer cells
- (2015) XIAOLING DING et al. Molecular Medicine Reports
- MiRNA Molecular Profiles in Human Medical Conditions: Connecting Lung Cancer and Lung Development Phenomena
- (2015) Mohamad-Reza Aghanoori et al. Asian Pacific Journal of Cancer Prevention
- Abstract B08: Triptolide has antitumor effects in lung cancer via Wnt pathway inhibition.
- (2014) Youqiang Li et al. CLINICAL CANCER RESEARCH
- miR-181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway
- (2014) Zhonghua Wei et al. FEBS LETTERS
- Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma
- (2013) Michael Roth et al. CANCER
- Osteosarcoma treatment – Where do we stand? A state of the art review
- (2013) Anja Luetke et al. CANCER TREATMENT REVIEWS
- Arsenic Trioxide Prevents Osteosarcoma Growth by Inhibition of GLI Transcription via DNA Damage Accumulation
- (2013) Shunsuke Nakamura et al. PLoS One
- Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs
- (2012) Xin Huang et al. LEUKEMIA & LYMPHOMA
- Triptolide: structural modifications, structure–activity relationships, bioactivities, clinical development and mechanisms
- (2012) Zhao-Li Zhou et al. NATURAL PRODUCT REPORTS
- MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene
- (2012) G Ke et al. ONCOGENE
- Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1*
- (2011) Hai-tao Meng et al. ACTA PHARMACOLOGICA SINICA
- Triptolide and its expanding multiple pharmacological functions
- (2011) Qiuyan Liu INTERNATIONAL IMMUNOPHARMACOLOGY
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- Zeb1 links epithelial-mesenchymal transition and cellular senescence
- (2008) Y. Liu et al. DEVELOPMENT
- A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
- (2008) Ulrike Burk et al. EMBO REPORTS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now